{"cluster": 48, "subcluster": 45, "abstract_summ": "Muscle injury or myalgia was the most common (19.2%, 95%CI 15.4\u201323.2%) neurologic symptom of COVID-19, followed by headache (10.9%, 95%CI 8.62\u201313.51%); dizziness (8.7%, 95%CI 5.02\u201313.43%); nausea with or without vomiting (4.6%, 95%CI 3.17\u20136.27%); concurrent cerebrovascular disease (4.4%, 95%CI 1.92\u20137.91%); and impaired consciousness (3.8%, 95%CI 0.16\u201312.04%).The prevalence of diabetes was 7.7 % (95CI 6.1\u20139.3 %), hypertension was 15.6 % (95CI 12.6\u201318.6 %), cardiovascular disease was 4.7 % (95CI 3.1\u20136.2 %), and malignancy was 1.2 % (95CI 0.5\u20131.8 %).The case severe rate and mortality is lower than that of SARS and MERS.BACKGROUND: Since novel coronavirus disease (COVID-19) emerged, various clinical features of COVID-19 have been reported.Among COVID-19 patients, fever (83.3% [95% CI 78.4\u201387.7]), cough (60.3% [54.2\u201366.3]), and fatigue (38.0% [29.8\u201346.5]) were the most common clinical symptoms.The presenting symptoms are mainly respiratory symptom, yet studies have reported nervous system involvement in the disease.", "title_summ": "The Novel Coronavirus Disease (COVID-19): A PRISMA Systematic Review and Meta-analysis of Clinical and Paraclinical characteristicsNeurologic Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-AnalysisClinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysisPrevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysisTrends in clinical features of novel coronavirus disease (COVID-19): A systematic review and meta-analysis of studies published from December 2019 to February 2020", "title_abstract_phrases": "The case severe rate and mortality is lower than that of SARS and MERS.Trends in clinical features of novel coronavirus disease (COVID-19): A systematic review and meta-analysis of studies published from December 2019 to February 2020BACKGROUND: Since novel coronavirus disease (COVID-19) emerged, various clinical features of COVID-19 have been reported.Muscle injury or myalgia was the most common (19.2%, 95%CI 15.4\u201323.2%) neurologic symptom of COVID-19, followed by headache (10.9%, 95%CI 8.62\u201313.51%); dizziness (8.7%, 95%CI 5.02\u201313.43%); nausea with or without vomiting (4.6%, 95%CI 3.17\u20136.27%); concurrent cerebrovascular disease (4.4%, 95%CI 1.92\u20137.91%); and impaired consciousness (3.8%, 95%CI 0.16\u201312.04%).The prevalence of diabetes was 7.7 % (95CI 6.1\u20139.3 %), hypertension was 15.6 % (95CI 12.6\u201318.6 %), cardiovascular disease was 4.7 % (95CI 3.1\u20136.2 %), and malignancy was 1.2 % (95CI 0.5\u20131.8 %).The Novel Coronavirus Disease (COVID-19): A PRISMA Systematic Review and Meta-analysis of Clinical and Paraclinical characteristicsAn outbreak of pneumonia, caused by a novel coronavirus (COVID-19) was Identified in China in Dec 2019.Among COVID-19 patients, fever (83.3% [95% CI 78.4\u201387.7]), cough (60.3% [54.2\u201366.3]), and fatigue (38.0% [29.8\u201346.5]) were the most common clinical symptoms."}